Protara Therapeutics, Inc. (TARA)
3.915
+0.04
(+1.16%)
USD |
NASDAQ |
Aug 25, 12:49
Protara Therapeutics Total Return Level : 3.87 for Aug. 24, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 24, 2026 | 3.87 |
| August 21, 2026 | 3.85 |
| August 20, 2026 | 3.90 |
| August 19, 2026 | 3.96 |
| August 18, 2026 | 3.98 |
| August 17, 2026 | 3.98 |
| August 14, 2026 | 3.97 |
| August 13, 2026 | 3.94 |
| August 12, 2026 | 3.89 |
| August 11, 2026 | 3.91 |
| August 10, 2026 | 4.11 |
| August 07, 2026 | 4.12 |
| August 06, 2026 | 4.10 |
| August 05, 2026 | 4.00 |
| August 04, 2026 | 4.01 |
| August 03, 2026 | 3.97 |
| July 31, 2026 | 3.92 |
| July 30, 2026 | 4.03 |
| July 29, 2026 | 3.81 |
| July 28, 2026 | 3.94 |
| July 27, 2026 | 4.04 |
| July 24, 2026 | 4.02 |
| July 23, 2026 | 4.04 |
| July 22, 2026 | 4.08 |
| July 21, 2026 | 4.09 |
| Date | Value |
|---|---|
| July 20, 2026 | 4.07 |
| July 17, 2026 | 4.10 |
| July 16, 2026 | 4.08 |
| July 15, 2026 | 4.12 |
| July 14, 2026 | 4.09 |
| July 13, 2026 | 4.18 |
| July 10, 2026 | 4.32 |
| July 09, 2026 | 4.20 |
| July 08, 2026 | 4.11 |
| July 07, 2026 | 4.27 |
| July 06, 2026 | 4.08 |
| July 02, 2026 | 4.06 |
| July 01, 2026 | 4.04 |
| June 30, 2026 | 3.82 |
| June 29, 2026 | 4.16 |
| June 26, 2026 | 4.12 |
| June 25, 2026 | 4.00 |
| June 24, 2026 | 4.03 |
| June 23, 2026 | 4.00 |
| June 22, 2026 | 4.11 |
| June 18, 2026 | 3.98 |
| June 17, 2026 | 4.07 |
| June 16, 2026 | 3.81 |
| June 15, 2026 | 3.94 |
| June 12, 2026 | 3.90 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| NovelStem International Corp. | 0.0095 |
| Brainstorm Cell Therapeutics, Inc. | 1.00 |
| Summit Therapeutics, Inc. | 12.73 |
| Kezar Life Sciences, Inc. | 7.29 |
| Clene, Inc. | 4.435 |